Our relatively recent study (Garbuzova-Davis et al., 2022) demonstrated the therapeutic potential of ApoA1 for endothelial cell repair under pathologic conditions reminiscent of ALS. This evidence concerns the gene APOA1 and amyotrophic lateral sclerosis.